Sat, Dec 20, 2014, 7:22 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

VIVUS Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • mofisher22 mofisher22 Jun 18, 2012 7:41 PM Flag

    Dr. told me will NOT prescribe VVUS

    I think the thing that worries a lot of docs is the cleft palate issue, I believe it is somewhere between 1 and 2 per cent. Those odds are pretty low, but , doing the math, at 1.25 per cent, that would be out of 100,000, about 1250 babies born with cleft palate. Can you imagine the docs that prescribe to those 1250 women, how they will be impacted, both professionally, and , financially, with their malpractice insurance going up. I have not heard much about docs concerns about lorcosirin, thought they laid to rest the issue of tumors in rats. Are they really going to make ARNA do extra stuff even with a delay? Why did they delay Quenexa exactly? I have actually spoken with several docs and their friends in Memphis, TN., just off the record , mostly at golf course. Out of about 10 who had any knowledge of them, one said they would prescribe both, one said would prescribe only Quenexa, 4 said only Lorcorsirin, and 3 or 4 said they would prescibe neither, preferring the old fashion diet and exercise, and avoiding any malpractice issues. Any one else got any info, I am trying to learn all I can, I own all 3 obesity stocks, but most heavily ARNA. Appreciate the info on ARNA, was not aware of the magnitude of their drugs side effects. glta

 
VVUS
3.32+0.15(+4.73%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.